PROSTATE-SPECIFIC ANTIGEN RESPONSE TO DEFERRED COMBINED ANDROGEN BLOCKADE THERAPY USING BICALUTAMIDE PREDICTS SURVIVAL AFTER SUBSEQUENT OESTROGEN AND DOCETAXEL THERAPIES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

✍ Scribed by Marc B. Garnick

• Book ID: 115199638
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 47 KB
• Volume: 110
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2012.11061.x